Testing decisions in the Pandemic: How do we use imperfect tests for COVID-19 (SARS-CoV-2) to make clinical decisions

Access status:

Open Access

Field	Value	Language
dc.contributor.author	Bell, Katy J.L.	en
dc.contributor.author	Stanaway, Fiona	en
dc.contributor.author	Irwig, Les	en
dc.contributor.author	Horvath, Andrea R	en
dc.contributor.author	Teixeira-Pinto, Armando	en
dc.contributor.author	Loy, Clement	en
dc.date.accessioned	2021-04-09T00:37:02Z
dc.date.available	2021-04-09T00:37:02Z
dc.date.issued	2020	en
dc.identifier.uri	https://hdl.handle.net/2123/24887
dc.identifier.uri	https://www.mja.com.au/journal/2020/testing-decisions-pandemic-how-do-we-use-imperfect-tests-covid-19-sars-cov-2-make
dc.description.abstract	This is the second article of a series on how to use diagnostic test accuracy evidence. In this article, we explain how diagnostic test accuracy estimates may be applied in clinical practice, using the example of coronavirus disease 2019 (COVID-19). Using clinical scenarios, we guide the reader through the process of applying estimates of diagnostic accuracy to change the pre-test probability of disease, and make clinical decisions about their patient.	en
dc.language.iso	en	en
dc.publisher	Wiley	en
dc.rights	Copyright All Rights Reserved	en
dc.subject	decision making	en
dc.subject	medical test	en
dc.subject	COVID-19	en
dc.title	Testing decisions in the Pandemic: How do we use imperfect tests for COVID-19 (SARS-CoV-2) to make clinical decisions	en
dc.type	Article	en
dc.subject.asrc	1117 Public Health and Health Services	en
usyd.faculty	SeS faculties schools::Faculty of Medicine and Health::Sydney School of Public Health	en
workflow.metadata.only	No	en